Literature DB >> 25920592

A novel large deletion (exons 12, 13) and a missense mutation (p.G46R) in the PAH in a Japanese patient with phenylketonuria.

Yoshihiro Maruo1, Masafumi Suzaki, Katsuyuki Matsui, Yu Mimura, Asami Mori, Haruo Shintaku, Yoshihiro Takeuchi.   

Abstract

BACKGROUND: Phenylketonuria (PKU) is caused by a defect in phenylalanine hydroxylase (PAH). More than 500 mutations have been reported for the gene encoding PAH. However, approximately 1%-5% of these include large deletions and large duplications that cannot be detected by conventional methods.
METHODS: In this report we tried to fully characterize a PAH-deficient patient. The patient was a 2-year-old Japanese boy who was diagnosed with classical PKU at the time of neonatal screening, which was confirmed by the tetrahydrobiopterin-loading test. PCR-related direct sequencing and multiplex ligation-dependent probe amplification (MLPA) were used to analyze of the PAH of the patient.
RESULTS: Using PCR-related direct sequencing method, we could detect only a heterozygous novel missense mutation: p.136G>C (p.G46R). A second mutation was detected by MLPA. The patient was heterozygous for a novel large deletion of exons 12 and 13: c.1200-?_1359+?del (EX12_13del). For genetic counseling, an accurate genetic diagnosis is often necessary.
CONCLUSIONS: Through a combination of MLPA and conventional methods, the success rate of PAH mutation identification can be close to 100%.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25920592     DOI: 10.1007/s12519-015-0020-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  9 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Low proportion of whole exon deletions causing phenylketonuria in Denmark and Germany.

Authors:  Lisbeth Birk Møller; Anders O H Nygren; Patrick Scott; Pia Hougaard; Jytte Bieber Nielsen; Caroline Hartmann; Flemming Güttler; Linda Tyfield; Johannes Zschocke
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

3.  Single exon deletions in the PAH gene in Polish PKU-patients.

Authors:  Miroslaw Bik-Multanowski; Jacek J Pietrzyk
Journal:  Mol Genet Metab       Date:  2008-04-02       Impact factor: 4.797

4.  RFLP-patterns in Japanese PKU families: new polymorphisms for the mutant phenylalanine hydroxylase gene.

Authors:  F K Trefz; M Yoshino; A Nishiyori; F Aengeneyndt; B Schmidt-Mader; U Lichter-Konecki; D S Konecki
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

5.  Identification of exonic deletions in the PAH gene causing phenylketonuria by MLPA analysis.

Authors:  Lourdes R Desviat; Belén Pérez; Magdalena Ugarte
Journal:  Clin Chim Acta       Date:  2006-05-12       Impact factor: 3.786

Review 6.  The G46S-hPAH mutant protein: a model to study the rescue of aggregation-prone PKU mutations by chaperones.

Authors:  João Leandro; Jaakko Saraste; Paula Leandro; Torgeir Flatmark
Journal:  Mol Genet Metab       Date:  2011-07-31       Impact factor: 4.797

7.  Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan.

Authors:  Yoshiyuki Okano; Satoshi Kudo; Yasuaki Nishi; Tomoko Sakaguchi; Kazuyoshi Aso
Journal:  J Hum Genet       Date:  2011-02-10       Impact factor: 3.172

8.  Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria.

Authors:  Yong Wha Lee; Dong Hwan Lee; Nam Doo Kim; Seung Tae Lee; Jee Young Ahn; Tae Youn Choi; You Kyoung Lee; Sun Hee Kim; Jong Won Kim; Chang Seok Ki
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

Review 9.  Phenylketonuria mutations in Europe.

Authors:  Johannes Zschocke
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.